Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Space42 (ADX:SPACE42) and Viasat (NASDAQ:VSAT) Form Equatys to Launch Global D2D Services

Space42 (ADX:SPACE42) and Viasat (NASDAQ:VSAT) have announced the formation of Equatys, a joint venture designed to enable global Direct-to-Device (D2D) connectivity and advance Mobile Satellite Services (MSS) into a 5G-ready network environment. The partnership aims to deliver the world’s largest coordinated spectrum block for …

Team Kalkine | 15 September 2025

Magna (NYSE:MGA) and XPENG Partner to Assemble EV Models in Europe from 2025

Magna International Inc. (NYSE:MGA) announced it has entered into a partnership with Chinese electric vehicle manufacturer XPENG to assemble two new electric vehicle models in Europe. Production is scheduled to begin in the third quarter of 2025 at Magna’s complete vehicle manufacturing facility in …

Team Kalkine | 15 September 2025

Hesai Technology (NASDAQ:HSAI) Expands Lidar Contract with U.S. Robotaxi Operator Through 2026

Hesai Technology Inc. (NASDAQ: HSAI) announced a contract expansion worth $40 million with a major U.S. robotaxi company for lidar system deliveries through 2026. Under the agreement, Hesai will act as the exclusive supplier for both long-range and short-range lidar units, supporting the operator’s …

Team Kalkine | 15 September 2025

Alamos Gold (NYSE:AGI) to Sell Turkish Assets to Tümad Madencilik for $470 Million

Alamos Gold Inc. (NYSE:AGI) announced it has entered into a definitive agreement to sell its Turkish subsidiary, which owns the Kirazlı, Ağı Dağı, and Çamyurt gold projects, to Tümad Madencilik for total cash consideration of $470 million.

Team Kalkine | 15 September 2025

NovoCure (NASDAQ: NVCR) Sees Mixed Analyst Ratings with Average Price Target Near USD 29

NovoCure Limited (NASDAQ: NVCR),a medical equipment company specializing in tumor treating fields (TTFields) devices for solid tumor cancers, currently holds a consensus analyst rating of"Moderate Buy,"according to MarketBeat Ratings. This consensus is derived from seven analysts covering the stock, with four recommending a buy …

Aditi Sarkar | 14 September 2025

Genius Sports (NYSE: GENI) Sees Price Target Raised Amid Mixed Analyst Ratings

Genius Sports Limited (NYSE: GENI), a technology provider for the sports, sports betting, and sports media sectors, recently had its target price raised by UBS Group from USD 11.00 to USD 13.00, maintaining a neutral rating, according to MarketBeat Ratings.

Aditi Sarkar | 14 September 2025

AtlasClear Holdings (NYSE American: ATCH) Reports 295% Surge in WDCO Net Income

AtlasClear Holdings (NYSE American: ATCH) has reported a sharp financial improvement for its wholly owned subsidiary, Wilson-Davis & Co. (WDCO), with full-year net income reaching USD 1,477,946, a 295% increase compared to the prior year. Revenue for the 12 months ended June 30, 2025, …

Team Kalkine | 12 September 2025

PENN Entertainment (NASDAQ: PENN) Reports Q2 Revenue of USD 1.77Bn, Net Loss Narrows to USD 18.3Mn

PENN Entertainment, Inc. (NASDAQ: PENN)offers casino gaming, sports content, and online betting across 28 North American jurisdictions. Its portfolio includes casinos, racetracks, and iCasino operations under brands such as Hollywood Casino, L’Auberge, ESPN BET, and the Score BET. The company operates through five segments: …

Aditi Sarkar | 12 September 2025

Tourmaline Bio (NASDAQ: TRML) Sees Analyst Downgrades, Consensus at “Hold”

Tourmaline Bio, Inc. (NASDAQ: TRML) operates as a clinical biotechnology company focused on developing therapies for immune and inflammatory diseases. Its lead asset, TOUR006, is a human anti-IL-6 monoclonal antibody designed to selectively bind interleukin-6, a proinflammatory cytokine implicated in various autoimmune and inflammatory …

Aditi Sarkar | 12 September 2025